Advertisement

Relevance of TSH evaluation in elderly in-patients with non-thyroidal illness

  • J. Rosenfarb
  • N. Sforza
  • R. Rujelman
  • Y. Morosan Allo
  • C. Parisi
  • E. Blanc
  • C. Frigerio
  • P. Fossati
  • D. Caruso
  • C. Faingold
  • T. Meroño
  • G. BrentaEmail author
Original Article
  • 38 Downloads

Abstract

Background

Non-thyroidal illness (NTI) is frequent in hospitalized patients. Its recovery is characterized by a raise in TSH levels. However, the clinical significance of high TSH levels at admission in hospitalized elderly patients with NTI remains uncertain.

Aim

To explore the relevance of baseline TSH evaluation in hospitalized elderly patients with NTI.

Methods

We examined the participants with NTI (n = 123) from our previous study (Sforza, 2017). NTI was defined as: low T3 (< 80 ng/dL) and normal or low total T4 in the presence of TSH values between 0.1 and 6.0 mU/L. Thyroid function tests were performed on day 1 and day 8 of the hospital stay. Positive TSH changes (+ ΔTSH) were considered when the day-8 TSH value increased more than the reference change value for TSH (+ 78%). Multiple logistic regression was used to evaluate the independent association of baseline TSH, sex, clinical comorbidities (by ACE-27) and medications with + ΔTSH.

Results

Out of 123 patients (77 ± 8 years, 52% female), 34 showed a + ΔTSH. These patients had a lower TSH at admission (p < 0.001) and intra-hospital mortality (p = 0.003) than the others. In multiple logistic regression, TSH > 2.11 mU/L at baseline was associated with reduced odds to show + ΔTSH [odds ratio (95 CI) 0.29 (0.11–0.75); p = 0.011] in a model adjusted by age, sex and ACE-27.

Discussion

Inappropriately higher TSH levels at admission in hospitalized elderly patients were associated with a reduced ability to raise their TSH levels later on. The present results confront the idea that TSH levels at admission are irrelevant in this clinical context.

Keywords

Thyroid function Non-thyroidal illness Elderly patients Mortality Critical illness TSH 

Notes

Acknowledgements

The authors would like to acknowledge all the medical and non-medical staff from the Internal Medicine and Laboratory Departments from the “Dr. César Milstein” Hospital for their cooperation with this study. Noelia Sforza has received additional support from a scholarship granted by the Comisión Nacional Salud Investiga, Ministerio de Salud de la República Argentina.

Author contributions

DC, CF, TM and GB designed the study and prepared the presentation to the Ethics Review Board of the “Dr. César Milstein” Hospital for approval. JR, NS, RR, AM, CP, and EB were in charge of the recruitment of the patients, performed the clinical evaluations, and registered the medications, the hospital stay and the causes of admission of all the subjects included. DC, CF and GB supervised the protocol development. CF and PF performed the biochemical measurements and filled the study database. TM performed the statistical analyses. JR and NS wrote the manuscript draft. CF, TM and GB reviewed and corrected the manuscript for submission. All the authors approved the final version of the manuscript.

Compliance with ethical standards

Conflict of interest

The author reports no conflicts of interest in this work.

Ethical approval

The study protocol was approved by the Ethics Committee from the Cesar Milstein Hospital. The study was conducted in compliance with the ethical principles for medical research involving human subjects (Declaration of Helsinki).

Informed consent

All the patients, or their relatives, signed the informed consent to participate in the study.

References

  1. 1.
    Van den Berghe G, De Zegher F, Bouillon R (1998) Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83(6):1827–1834PubMedGoogle Scholar
  2. 2.
    Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev 3(2):164–217CrossRefGoogle Scholar
  3. 3.
    Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23(1):38–89CrossRefGoogle Scholar
  4. 4.
    Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23(1):78–83CrossRefGoogle Scholar
  5. 5.
    Docter R, Krenning E, Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 39(5):499–518CrossRefGoogle Scholar
  6. 6.
    De Vries E, Fliers E, Boelen A (2015) The molecular basis of the non-thyroidal illness syndrome. J Endocrinol 225(3):67–81.  https://doi.org/10.1530/joe-15-0133 CrossRefGoogle Scholar
  7. 7.
    Mingote E, Meroño T, Rujelman R, Marquez A, Fossati P, Gurfinkiel M, Schnitman M, Brites F, Faingold C, Brenta G (2012) High TSH and low T4 as prognostic markers in older patients. HORMONES 11(3):350–355CrossRefGoogle Scholar
  8. 8.
    Fliers E, Bianco A, Langouche L, Boelen A (2015) Thyroid function in critically ill patients. Lancet Diabetes Endocrinol 3(10):816–825.  https://doi.org/10.1016/s2213-8587(15)00225-9 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Iglesias P, Munoz A, Prado F, Guerrero MT, Macias MC, Ridruejo E, Tajada P, Diez JJ (2009) Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol 70(6):961–967.  https://doi.org/10.1111/j.1365-2265.2008.03421.x CrossRefGoogle Scholar
  10. 10.
    McIver B, Gorman C (1997) Euthyroid sick syndrome: an overview. Thyroid 7(1):125–132CrossRefGoogle Scholar
  11. 11.
    Warner M, Beckett G (2010) Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 205(1):1–13.  https://doi.org/10.1677/joe-09-0412 CrossRefGoogle Scholar
  12. 12.
    Ayaz T, Sahin SB, Sahin OZ, Bilir O, Rakici H (2014) Factors affecting mortality in elderly patients hospitalized for nonmalignant reasons. J Aging Res 2014:584315.  https://doi.org/10.1155/2014/584315 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Maldonado LS, Murata GH, Hershman JM, Braunstein GD (1992) Do thyroid function tests independently predict survival in the critically ill? Thyroid 2(2):119–123CrossRefGoogle Scholar
  14. 14.
    Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Scholmerich J, Wrede CE (2007) Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 56(2):239–244.  https://doi.org/10.1016/j.metabol.2006.09.020 CrossRefPubMedGoogle Scholar
  15. 15.
    Tognini S, Marchini F, Dardano A, Polini A, Ferdeghini M, Castiglioni M, Monzani F (2010) Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing 39(1):46–50.  https://doi.org/10.1093/ageing/afp197 CrossRefGoogle Scholar
  16. 16.
    Delpont B, Aboa-Eboule C, Durier J, Petit JM, Daumas A, Legris N, Daubail B, Giroud M, Bejot Y (2016) Associations between thyroid stimulating hormone levels and both severity and early outcome of patients with ischemic stroke. Eur Neurol 76(3–4):125–131.  https://doi.org/10.1159/000449055 CrossRefPubMedGoogle Scholar
  17. 17.
    Kaptein EM, LoPresti JS, Kaptein MJ (2014) Is an isolated TSH elevation in chronic nonthyroidal illness “subclinical hypothyroidism”? J Clin Endocrinol Metab 99(11):4015–4026CrossRefGoogle Scholar
  18. 18.
    Spencer C, Elgen A, Shen D, Duds M, Quails S, Weiss S, Nicoloft J (1987) specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33(8):1391–1396Google Scholar
  19. 19.
    Sforza N, Rosenfarb J, Rujelman R, Rosmarin M, Blanc E, Frigerio C, Fossati P, Caruso D, Faingold C, Merono T, Brenta G (2017) Hypothyroidism in hospitalized elderly patients: a sign of worse prognosis. J Endocrinol Investig 40(12):1303–1310.  https://doi.org/10.1007/s40618-017-0690-2 CrossRefGoogle Scholar
  20. 20.
    Fraser CG (2001) Biological variation: from principles to practice. American Association of Clinical Chemistry, WashingtonGoogle Scholar
  21. 21.
    Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002) Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87(3):1068–1072.  https://doi.org/10.1210/jcem.87.3.8165 CrossRefGoogle Scholar
  22. 22.
    Iglesias P, Muñoz A, Prado F, Guerrero MT, Macias MC, Ridruejo E, Tajada P, Garcia-Arevalo C, Diez JJ (2010) Serum thyrotropin concentration is an early marker of normalization of low triiodothyronine syndrome in aged hospitalized patients after discharge. J Endocrinol Investig 33(9):607–611.  https://doi.org/10.3275/6870,  https://doi.org/10.1007/bf03346657
  23. 23.
    Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82(12):4032–4036Google Scholar
  24. 24.
    Mendoza A, Hollenberg AN (2017) New insights into thyroid hormone action. Pharmacol Ther 173:135–145.  https://doi.org/10.1016/j.pharmthera.2017.02.012 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Juarez-Cedillo T, Basurto-Acevedo L, Vega-Garcia S, Sanchez-Rodriguez Martha A, Retana-Ugalde R, Juarez-Cedillo E, Gonzalez-Melendez Roberto C, Escobedo-de-la-Pena J (2017) Prevalence of thyroid dysfunction and its impact on cognition in older mexican adults: (SADEM study). J Endocrinol Investig 40(9):945–952.  https://doi.org/10.1007/s40618-017-0654-6 CrossRefGoogle Scholar
  26. 26.
    Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ (2018) Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid 28(9):1101–1110.  https://doi.org/10.1089/thy.2017.0414 CrossRefPubMedGoogle Scholar
  27. 27.
    Peeters RP, Wouters PJ, Van Toor H, Kaptein E, Visser TJ, Van den Berghe G (2005) Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90(8):4559–4565.  https://doi.org/10.1210/jc.2005-0535 CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2018

Authors and Affiliations

  • J. Rosenfarb
    • 1
  • N. Sforza
    • 1
  • R. Rujelman
    • 1
  • Y. Morosan Allo
    • 1
  • C. Parisi
    • 1
  • E. Blanc
    • 1
  • C. Frigerio
    • 1
  • P. Fossati
    • 1
  • D. Caruso
    • 1
  • C. Faingold
    • 1
  • T. Meroño
    • 2
  • G. Brenta
    • 1
    Email author
  1. 1.Thyroid Unit, Department of Endocrinology and MetabolismUnidad Asistencial Dr. César Milstein/PAMI-INSSJPBuenos AiresArgentina
  2. 2.Depto. de Bioquímica Clínica, Facultad de Farmacia y BioquímicaUniversidad de Buenos AiresBuenos AiresArgentina

Personalised recommendations